Contract award · W81XWH19C0145
JW180076 PHASE III CLINICAL TRIAL
Awarded to SANARIA INC. · CAGE 30DP1
Latest reported total obligated
Not reported
Net observed obligations
$3.4M
Observed contract actions
7
Observed period
FY2019–FY2024
Reported totals are cumulative values from the latest available award record. Observed obligations and actions reflect Mimir's FY2019 onward transaction window and may omit earlier activity.
Award parties and scope
ContractorSANARIA INC.
CAGE30DP1
CustomerDepartment of the Army
Performance locationROCKVILLE, MARYLAND, UNITED STATES
Procurement details
First observed actionSep 20, 2019
Latest observed actionJun 3, 2024
PSCAN93
NAICS541715 · Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
CompetitionNOT COMPETED
PricingFIXED PRICE LEVEL OF EFFORT
Annual observed obligations
FY2019
$3M
FY2020
$98.3K
FY2022
$300K
FY2024
-$0
Continue exploring
Ask Mimir about W81XWH19C0145
Continue with this contract award already in context.
ContinueExplore the full award in Mimir
Open the complete action history and connected analysis in the platform.